Reading for this module should include the section on Thyroid Ultrasonography in Thyroid Disease Manager, or alternative sources. These could include chapters in Endocrinology, Edition III, comparable chapters in Endocrinology Edition IV (when released), or appropriate chapters in The Thyroid. Please note that many questions have more than one correct answer among the multiple possible responses offered.
Anticipated study and testing time for this module is 2 hours. After reading the material, print out his page, complete the test, fill in required personal information, and send the page with payment to
Center for Continuing Medical Education, 950 E 61st St., University of Chicago,
Chicago, IL 60637., with payment of $45.
After satisfactory completion of the examination, a certificate will be returned by mail.
1. Sonography
depicts the internal structure of the thyroid gland and |
|
| A. Without using ionizing radiation | |
| B. Iodine containing contrast medium improves the image | |
| C. High frequency sound waves in the megahertz range are used | |
| D. Gadolinium administration improves the image | |
| E. A+C | |
2. Thyroid
sonography: |
|
| A. Does not cause damage to thyroid tissue | |
| B. Does not require discontinuation of any medication | |
| C. Swallowing must be avoided | |
| D. A+B | |
| E. A+B+C | |
3. Sonography of the neck shows that: |
|
| A. The thyroid gland is slightly more echo-dense than the adjacent structures and has a homogenous ground glass appearance | |
| B. The esophagus may be demonstrated behind the medial part of the left thyroid lobe, especially if it is distended | |
| C. The air-filled trachea does not transmit the ultrasound | |
| D. The parathyroid glands are observed only when they are enlarged and are less dense ultrasonically than thyroid tissue | |
| E. A+B+C+D | |
| A. Plays little or no useful role in the management of patients who have a palpable thyroid which is otherwise totally normal to palpation | |
| B. Is cost effective when there is a palpable thyroid nodule | |
| C. Is necessary to supplement or confirm a physical examination | |
D.
Differentiates adenoma and carcinoma with a reliability of |
|
| E. A+B+C | |
5. In a patient with a goiter sonography may be used to: |
|
| A. Answer
a specific clinical question about the anatomy of a goiter |
|
| B. Essentially exclude cancer when there is a dominant palpable nodule and the gland is multinodular | |
| C. Diagnose as cancer a tender or hard spot when the echo pattern is solid and distinct from the rest of the goiter | |
| D. Differentiate Graves and Hashimotos diseases when Doppler examination shows hypervascularity | |
| E. A + B | |
| A. A hyperdense echo pattern |
|
| B. A halo |
|
| C. Microcalcifications |
|
| D. A specific vascular pattern on Doppler examination |
|
| E. An irregular margin |
|
| A. Non-palpable nodules increase with age to involve
approximately 50% of older adults especially women |
|
| B. Sonography may show
that a solitary nodule on palpation really is a clinically palpable nodule in a gland that
is subclinically multinodular |
|
| C. Elevated thyroglobulin in the presence of
micronodules suggests cancer |
|
| D. A+B |
|
| E. A+B+C |
|
| A. The risks include bleeding and infection |
|
| B. It is most useful for nodules that are
approximately 0.5 cm. in diameter |
|
| C. It improves accuracy for small nodules or those
with cystic degeneration |
|
| D. A+B+C |
|
| E. A+C |
|
| A. After thyroidectomy for cancer, nodules and
adenopathy that are detected by sonography are more likely to represent cancer when the
concentration of thyroglobulin is elevated |
|
| B. Sonography may detect cancer even before it has
grown sufficiently large to be palpable |
|
| C. In patients in whom thyroid carcinoma has been
diagnosed as the result of metastases to bone, lung or cervical nodes, sonography can
detect an occult thyroid primary tumor even when the thyroid gland is normal to palpation |
|
| D. A |
|
| E. A+B+C |
|
| A. An enlarged lymph node and a parathyroid adenoma |
|
| B. Thyroid adenoma and carcinoma |
|
| C. Hashimotos disease and lymphoma |
|
| D. Cyst and blood vessel |
|
| E. Toxic
autonomous nodule and non toxic nodule |
|
| Answer Sheet | |||||
| Enter "True" or "False" in the appropriate boxes. | |||||
| A (True/False) | B (True/False) | C (True/False) | D (True/False) |
E (True/False) |
|
| 1 | |||||
| 2 | |||||
| 3 | |||||
| 4 | |||||
| 5 | |||||
| 6 | |||||
| 7 | |||||
| 8 | |||||
| 9 | |||||
| 10 | |||||
| 11 | |||||
| 12 | |||||
| 13 | |||||
| 14 | |||||
| 15 | |||||
Please give us your
overall evaluation of this program: (circle
response)
Excellent Poor
5 4 3 2 1
Was there a topic not covered you would
have liked to have had presented? Please specify.
Will use of this program change the way
in which you manage patients?
Yes __ No __ Comments:
Do you believe the presentations
contained pharmaceutical industry bias? Yes
__ No __ Comments:
I certify that I spent three hours in
preparation and examination for this module-
(Signature)___________________________ Date________________
Name_________________________
Street__________________________
City_________________ State______ Zip
Code_____________ Country_____
Payment-
Credit Card Type______
Number________________ Exp.Date___/___
Check_____ Tel
#____-_____-________
Email
address-(Optional)_______________________________________